Hematology, Transfusion and Cell Therapy (Oct 2020)

Efficacy and safety of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment: results of the phase 2 dare study

  • E. Terpos,
  • A. Symeonidis,
  • S. Delimpasi,
  • E. Zamagni,
  • E. Katodritou,
  • E. Rivolti,
  • M. Kyrtsonis,
  • D. Fotiou,
  • N. Kanellias,
  • M. Migkou,
  • M. Roussou,
  • M. Gavriatopoulou,
  • E. Hatjiharissi,
  • M. Cavo,
  • M. Dimopoulos

Journal volume & issue
Vol. 42
pp. 22 – 23

Abstract

Read online

No abstracts available.